A new wave of weight-loss therapies aims to be better than today’s GLP-1s

06.06.26 23:10 Uhr

Werte in diesem Artikel
Aktien

SGD 0,00 SGD 33,33%

Retatrutide is one of those drugs. It helped people lose a massive amount of weight in clinical trials. It also improved sleep apnea and knee pain.Weiter zum vollständigen Artikel bei MarketWatch

Quelle: MarketWatch

Nachrichten zu New Wave Holdings Ltd